Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

234 Results

Regimen

EVERLENV

Cancer Type:

Genitourinary,

Renal cell / Kidney

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Drugs Used:

lenvatinib (Unfunded),

everolimus (Unfunded)

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Dec 2019

Guidelines and Advice

Minimal Residual Disease Testing in Acute Leukemia

Status: Current
ID: MOTAC-6
Version: 2

Sep 2020

Guidelines and Advice

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Status: Current
ID: GL 4-18
Version: N/A

Sep 2020

Guidelines and Advice

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Status: Current

Oct 2019

Guidelines and Advice

Baseline Staging Imaging for Distant Metastasis in Women with Stage I, II, and III Breast Cancer

Status: Current
ID: GL 1-14
Version: 3

Oct 2019

Guidelines and Advice

Organizational Guidance for the Care of Patients with Head and Neck Cancer in Ontario

Status: Current
ID: GL 5-3ORG
Version: 2

Apr 2019

Pages